Promising Applications of Nanoparticles in the Treatment of Hearing Loss
Open Access
- 7 October 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Abstract
Hearing loss is one of the most common disabilities affecting both children and adults worldwide. However, traditional treatment of hearing loss has some limitations, particularly in terms of drug delivery system as well as diagnosis of ear imaging. The blood–labyrinth barrier (BLB), the barrier between the vasculature and fluids of the inner ear, restricts entry of most blood-borne compounds into inner ear tissues. Nanoparticles (NPs) have been demonstrated to have high biocompatibility, good degradation, and simple synthesis in the process of diagnosis and treatment, which are promising for medical applications in hearing loss. Although previous studies have shown that NPs have promising applications in the field of inner ear diseases, there is still a gap between biological research and clinical application. In this paper, we aim to summarize developments and challenges of NPs in diagnostics and treatment of hearing loss in recent years. This review may be useful to raise otology researchers’ awareness of effect of NPs on hearing diagnosis and treatment.Keywords
Funding Information
- Zhongnan Hospital of Wuhan University
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
This publication has 106 references indexed in Scilit:
- Biocompatible near-infrared fluorescent nanoparticles for macro and microscopic in vivo functional bioimagingBiomedical Optics Express, 2014
- Highly stable polymer coated nano-clustered silver plates: a multimodal optical contrast agent for biomedical imagingNanotechnology, 2014
- Distribution of Dexamethasone and Preservation of Inner Ear Function following Intratympanic Delivery of a Gel-Based FormulationAudiology and Neurotology, 2010
- Hearing LossMedical Clinics of North America, 2010
- Drug Delivery for Treatment of Inner Ear Disease: Current State of KnowledgeEar & Hearing, 2010
- Dose-Dependent Sustained Release of Dexamethasone in Inner Ear Cochlear Fluids Using a Novel Local Delivery ApproachAudiology and Neurotology, 2009
- Immunosuppressive Therapy for Autoimmune Inner Ear DiseaseImmunotherapy, 2009
- Cubic versus Spherical Magnetic Nanoparticles: The Role of Surface AnisotropyJournal of the American Chemical Society, 2008
- Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological ApplicationsChemical Reviews, 2008
- The 5-Year Incidence and Progression of Hearing LossJAMA Otolaryngology–Head & Neck Surgery, 2003